Technical Document: Examination of the Membrane Filter Method for Microbio μ3D
Study on the Membrane Filter Method of the Microbio μ3D Auto Scanner
This technical document presents the results of verifying the optimal MF for use with the Microbio μ3D Auto Scanner. The Microbio μ3D Auto Scanner is a system that continuously monitors the growth of bacteria using the mixed culture plate method, plate spread method, and membrane filter method. While based on the culture methods used in official or standard viable cell count tests, it allows for measurement of the number of bacteria in or on the medium much more quickly and accurately than visual measurement. 【Overview of Contents】 ■ Purpose ■ Materials and Methods ■ Colony Growth Curves and Petri Dish Images from the MF Method ■ Conclusion ■ Introduction to the Microbio μ3D Auto Scanner For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
**Content of Publication** ■Purpose - To verify the optimal MF for use with the Microbio μ3D Auto Scanner ■Materials and Methods - Test strains - Membrane filters - Sample preparation and measurement conditions for the MF method - Verification of initial detection time of colonies - Measurement results - Discussion ■Colony growth curves and petri dish images from the MF method ■Conclusion - It has been confirmed that the MF used for the Microbio μ3D Auto Scanner is the plain type without grid lines on the filter surface, which is optimal. ■Introduction to the Microbio μ3D Auto Scanner *For more details, please refer to the catalog or feel free to contact us.*
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.